Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phase II randomised study
European Journal of Cancer2014Vol. 50(17), pp. 2975–2982
Citations Over TimeTop 12% of 2014 papers
Jean-Marc Phelip, Véronique Vendrely, Florian Rostain, Fabien Subtil, Jean-Louis Jouve, Mohamed Gasmi, Pierre Michel, K. Le Malicot, Denis Smith, Jean-François Seitz, Jean-Pierre Fauchart, P Martin, Jaafar Bennouna, Thierry Morin, Isabelle Bonnet, P. Maingon, Côme Lepage, Bruno Chauffert
Related Papers
- → Supraadditive effect of 2 ′ ,2 ′ -difluorodeoxycytidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines(1999)149 cited
- → Radiotherapy Combined with Gemcitabine and Oxaliplatin in Pancreatic Cancer Cells(2008)25 cited
- → Coadministration of oxaliplatin does not influence the pharmacokinetics of gemcitabine(2006)6 cited
- → Efficiency and Tolerance of Aranose Combinations with Cisplatin and Gemcitabine in Experimental Lung Cancer(2009)1 cited
- Treatment of Advanced Pancreatic Cancer with Combination of Gemcitabine and Oxaliplatin(2005)